Malignant liver tumours
The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the bac...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Hughes, Michael J. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Latent variable mixture modelling and individual treatment prediction - Saunders, Rob ELSEVIER, 2019, Abingdon |
|---|---|
| Übergeordnetes Werk: |
volume:32 ; year:2014 ; number:12 ; pages:655-660 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.mpsur.2014.10.002 |
|---|
| Katalog-ID: |
ELV03380219X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV03380219X | ||
| 003 | DE-627 | ||
| 005 | 20230625195045.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mpsur.2014.10.002 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014008000002.pica |
| 035 | |a (DE-627)ELV03380219X | ||
| 035 | |a (ELSEVIER)S0263-9319(14)00207-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 150 |a 610 |q VZ |
| 084 | |a 77.20 |2 bkl | ||
| 084 | |a 77.75 |2 bkl | ||
| 084 | |a 44.91 |2 bkl | ||
| 100 | 1 | |a Hughes, Michael J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Malignant liver tumours |
| 264 | 1 | |c 2014transfer abstract | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. | ||
| 520 | |a The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. | ||
| 650 | 7 | |a Chemotherapy |2 Elsevier | |
| 650 | 7 | |a radiofrequency ablation (RFA) |2 Elsevier | |
| 650 | 7 | |a trans-arterial chemoembolization (TACE) |2 Elsevier | |
| 650 | 7 | |a colorectal liver metastases |2 Elsevier | |
| 650 | 7 | |a cholangiocarcinoma |2 Elsevier | |
| 650 | 7 | |a resection |2 Elsevier | |
| 650 | 7 | |a hepatocellular carcinoma |2 Elsevier | |
| 700 | 1 | |a Harrison, Ewen M. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Medicine Publishing Company |a Saunders, Rob ELSEVIER |t Latent variable mixture modelling and individual treatment prediction |d 2019 |g Abingdon |w (DE-627)ELV003386074 |
| 773 | 1 | 8 | |g volume:32 |g year:2014 |g number:12 |g pages:655-660 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.mpsur.2014.10.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 77.20 |j Behaviorismus |q VZ |
| 936 | b | k | |a 77.75 |j Verhaltenstherapie |q VZ |
| 936 | b | k | |a 44.91 |j Psychiatrie |j Psychopathologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 32 |j 2014 |e 12 |h 655-660 |g 6 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m j h mj mjh |
|---|---|
| matchkey_str |
hughesmichaeljharrisonewenm:2014----:ainnlvr |
| hierarchy_sort_str |
2014transfer abstract |
| bklnumber |
77.20 77.75 44.91 |
| publishDate |
2014 |
| allfields |
10.1016/j.mpsur.2014.10.002 doi GBVA2014008000002.pica (DE-627)ELV03380219X (ELSEVIER)S0263-9319(14)00207-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Hughes, Michael J. verfasserin aut Malignant liver tumours 2014transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Elsevier Harrison, Ewen M. oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:32 year:2014 number:12 pages:655-660 extent:6 https://doi.org/10.1016/j.mpsur.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 32 2014 12 655-660 6 045F 610 |
| spelling |
10.1016/j.mpsur.2014.10.002 doi GBVA2014008000002.pica (DE-627)ELV03380219X (ELSEVIER)S0263-9319(14)00207-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Hughes, Michael J. verfasserin aut Malignant liver tumours 2014transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Elsevier Harrison, Ewen M. oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:32 year:2014 number:12 pages:655-660 extent:6 https://doi.org/10.1016/j.mpsur.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 32 2014 12 655-660 6 045F 610 |
| allfields_unstemmed |
10.1016/j.mpsur.2014.10.002 doi GBVA2014008000002.pica (DE-627)ELV03380219X (ELSEVIER)S0263-9319(14)00207-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Hughes, Michael J. verfasserin aut Malignant liver tumours 2014transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Elsevier Harrison, Ewen M. oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:32 year:2014 number:12 pages:655-660 extent:6 https://doi.org/10.1016/j.mpsur.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 32 2014 12 655-660 6 045F 610 |
| allfieldsGer |
10.1016/j.mpsur.2014.10.002 doi GBVA2014008000002.pica (DE-627)ELV03380219X (ELSEVIER)S0263-9319(14)00207-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Hughes, Michael J. verfasserin aut Malignant liver tumours 2014transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Elsevier Harrison, Ewen M. oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:32 year:2014 number:12 pages:655-660 extent:6 https://doi.org/10.1016/j.mpsur.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 32 2014 12 655-660 6 045F 610 |
| allfieldsSound |
10.1016/j.mpsur.2014.10.002 doi GBVA2014008000002.pica (DE-627)ELV03380219X (ELSEVIER)S0263-9319(14)00207-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Hughes, Michael J. verfasserin aut Malignant liver tumours 2014transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Elsevier Harrison, Ewen M. oth Enthalten in Medicine Publishing Company Saunders, Rob ELSEVIER Latent variable mixture modelling and individual treatment prediction 2019 Abingdon (DE-627)ELV003386074 volume:32 year:2014 number:12 pages:655-660 extent:6 https://doi.org/10.1016/j.mpsur.2014.10.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 77.20 Behaviorismus VZ 77.75 Verhaltenstherapie VZ 44.91 Psychiatrie Psychopathologie VZ AR 32 2014 12 655-660 6 045F 610 |
| language |
English |
| source |
Enthalten in Latent variable mixture modelling and individual treatment prediction Abingdon volume:32 year:2014 number:12 pages:655-660 extent:6 |
| sourceStr |
Enthalten in Latent variable mixture modelling and individual treatment prediction Abingdon volume:32 year:2014 number:12 pages:655-660 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Behaviorismus Verhaltenstherapie Psychiatrie Psychopathologie |
| institution |
findex.gbv.de |
| topic_facet |
Chemotherapy radiofrequency ablation (RFA) trans-arterial chemoembolization (TACE) colorectal liver metastases cholangiocarcinoma resection hepatocellular carcinoma |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Latent variable mixture modelling and individual treatment prediction |
| authorswithroles_txt_mv |
Hughes, Michael J. @@aut@@ Harrison, Ewen M. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV003386074 |
| dewey-sort |
3610 |
| id |
ELV03380219X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03380219X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625195045.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.mpsur.2014.10.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014008000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03380219X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0263-9319(14)00207-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.91</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hughes, Michael J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Malignant liver tumours</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">radiofrequency ablation (RFA)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">trans-arterial chemoembolization (TACE)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">colorectal liver metastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cholangiocarcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">resection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">hepatocellular carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harrison, Ewen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Medicine Publishing Company</subfield><subfield code="a">Saunders, Rob ELSEVIER</subfield><subfield code="t">Latent variable mixture modelling and individual treatment prediction</subfield><subfield code="d">2019</subfield><subfield code="g">Abingdon</subfield><subfield code="w">(DE-627)ELV003386074</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:655-660</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.mpsur.2014.10.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.20</subfield><subfield code="j">Behaviorismus</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.75</subfield><subfield code="j">Verhaltenstherapie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.91</subfield><subfield code="j">Psychiatrie</subfield><subfield code="j">Psychopathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2014</subfield><subfield code="e">12</subfield><subfield code="h">655-660</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Hughes, Michael J. |
| spellingShingle |
Hughes, Michael J. ddc 610 ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Malignant liver tumours |
| authorStr |
Hughes, Michael J. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV003386074 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 150 - Psychology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl Malignant liver tumours Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma Elsevier |
| topic |
ddc 610 ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma |
| topic_unstemmed |
ddc 610 ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma |
| topic_browse |
ddc 610 ddc 150 bkl 77.20 bkl 77.75 bkl 44.91 Elsevier Chemotherapy Elsevier radiofrequency ablation (RFA) Elsevier trans-arterial chemoembolization (TACE) Elsevier colorectal liver metastases Elsevier cholangiocarcinoma Elsevier resection Elsevier hepatocellular carcinoma |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
e m h em emh |
| hierarchy_parent_title |
Latent variable mixture modelling and individual treatment prediction |
| hierarchy_parent_id |
ELV003386074 |
| dewey-tens |
610 - Medicine & health 150 - Psychology |
| hierarchy_top_title |
Latent variable mixture modelling and individual treatment prediction |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV003386074 |
| title |
Malignant liver tumours |
| ctrlnum |
(DE-627)ELV03380219X (ELSEVIER)S0263-9319(14)00207-5 |
| title_full |
Malignant liver tumours |
| author_sort |
Hughes, Michael J. |
| journal |
Latent variable mixture modelling and individual treatment prediction |
| journalStr |
Latent variable mixture modelling and individual treatment prediction |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 100 - Philosophy & psychology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
655 |
| author_browse |
Hughes, Michael J. |
| container_volume |
32 |
| physical |
6 |
| class |
610 610 DE-600 150 610 VZ 77.20 bkl 77.75 bkl 44.91 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Hughes, Michael J. |
| doi_str_mv |
10.1016/j.mpsur.2014.10.002 |
| dewey-full |
610 150 |
| title_sort |
malignant liver tumours |
| title_auth |
Malignant liver tumours |
| abstract |
The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. |
| abstractGer |
The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. |
| abstract_unstemmed |
The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
12 |
| title_short |
Malignant liver tumours |
| url |
https://doi.org/10.1016/j.mpsur.2014.10.002 |
| remote_bool |
true |
| author2 |
Harrison, Ewen M. |
| author2Str |
Harrison, Ewen M. |
| ppnlink |
ELV003386074 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.mpsur.2014.10.002 |
| up_date |
2024-07-06T19:30:19.676Z |
| _version_ |
1803859231692029952 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03380219X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625195045.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.mpsur.2014.10.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014008000002.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03380219X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0263-9319(14)00207-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.20</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.75</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.91</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hughes, Michael J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Malignant liver tumours</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">radiofrequency ablation (RFA)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">trans-arterial chemoembolization (TACE)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">colorectal liver metastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cholangiocarcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">resection</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">hepatocellular carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harrison, Ewen M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Medicine Publishing Company</subfield><subfield code="a">Saunders, Rob ELSEVIER</subfield><subfield code="t">Latent variable mixture modelling and individual treatment prediction</subfield><subfield code="d">2019</subfield><subfield code="g">Abingdon</subfield><subfield code="w">(DE-627)ELV003386074</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:32</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:655-660</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.mpsur.2014.10.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.20</subfield><subfield code="j">Behaviorismus</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.75</subfield><subfield code="j">Verhaltenstherapie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.91</subfield><subfield code="j">Psychiatrie</subfield><subfield code="j">Psychopathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">32</subfield><subfield code="j">2014</subfield><subfield code="e">12</subfield><subfield code="h">655-660</subfield><subfield code="g">6</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.399164 |